Education
About Us
Working with TipRanks
Follow Us
Themis Medicare Limited (IN:THEMISMED)
:THEMISMED
THEMISMED Stock Chart & Stats
₹102.50
₹17.25(6.68%)
At close: 4:00 PM EST
₹102.50
₹17.25(6.68%)
Day’s Range― - ―
52-Week Range₹73.79 - ₹179.25
Previous CloseN/A
Volume256.77K
Average Volume (3M)6.87K
Market Cap
₹7.19B
Enterprise Value₹8.06B
Total Cash (Recent Filing)₹189.59M
Total Debt (Recent Filing)₹955.64M
Price to Earnings (P/E)22.9
Beta1.75
Next Earnings
May 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.48%
Share Statistics
EPS (TTM)1.10
Shares Outstanding92,100,120
10 Day Avg. Volume6,301
30 Day Avg. Volume6,868
Financial Highlights & Ratios
PEG Ratio-1.45
Price to Book (P/B)3.39
Price to Sales (P/S)3.37
P/FCF Ratio70.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Gross Profit MarginsSustained high gross margins indicate efficient production and pricing power in core formulations. Over the next 2–6 months this supports durable cash generation, funds R&D or capex, and provides a buffer against raw-material cost shifts versus lower-margin peers.
Balance Sheet StrengthA stable balance sheet with a healthy equity ratio and managed leverage provides financing flexibility and lowers refinancing risk. This structural strength supports capacity expansion, regulatory compliance spending, and resilience to industry headwinds over the medium term.
Cash Flow RecoveryImproving operating cash flow and free cash flow recovery demonstrate the company's ability to convert operations into cash. Durable cash generation reduces dependence on external funding, enables reinvestment or deleveraging, and strengthens financial stability over months.
Bears Say
Declining RevenueA roughly 22% reported revenue decline is a material structural concern; sustained top-line contraction erodes scale, pressures gross margins and fixed-cost absorption, and makes it harder to fund product development or sustain distribution investments in the medium term.
Earnings DeclineA steep negative EPS growth (>100%) signals significant earnings strain or one-off losses. Persistently weak earnings reduce retained earnings and internal funding capacity, increase reliance on external capital, and constrain strategic investments over the coming months.
Net Profit Margin VolatilityVolatile and recently declining net margins suggest inconsistent expense control or pricing pressure. Over 2–6 months this can damage operating leverage and cash conversion, making earnings recovery harder even if revenue stabilizes and increasing execution risk.
Themis Medicare Limited News
THEMISMED FAQ
What was Themis Medicare Limited’s price range in the past 12 months?
Themis Medicare Limited lowest stock price was ₹73.79 and its highest was ₹179.25 in the past 12 months.
What is Themis Medicare Limited’s market cap?
Themis Medicare Limited’s market cap is ₹7.19B.
When is Themis Medicare Limited’s upcoming earnings report date?
Themis Medicare Limited’s upcoming earnings report date is May 27, 2026 which is in 73 days.
How were Themis Medicare Limited’s earnings last quarter?
Themis Medicare Limited released its earnings results on Feb 13, 2026. The company reported ₹1.096 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.096.
Is Themis Medicare Limited overvalued?
According to Wall Street analysts Themis Medicare Limited’s price is currently Overvalued.
Does Themis Medicare Limited pay dividends?
Themis Medicare Limited pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.48%. See more information on Themis Medicare Limited dividends here
What is Themis Medicare Limited’s EPS estimate?
Themis Medicare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Themis Medicare Limited have?
Themis Medicare Limited has 92,100,120 shares outstanding.
What happened to Themis Medicare Limited’s price movement after its last earnings report?
Themis Medicare Limited reported an EPS of ₹1.096 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.41%.
Which hedge fund is a major shareholder of Themis Medicare Limited?
Currently, no hedge funds are holding shares in IN:THEMISMED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Themis Medicare Limited
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations for use in various therapeutic areas, including anti-infective, antimalarial, anti-tuberculosis, cardiology, health and nutrition, oncology, ophthalmology, and pain management. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was incorporated in 1969 and is headquartered in Mumbai, India.
Technical Analysis
Bliss Gvs Pharma Limited
―
Jagsonpal Pharmaceuticals Ltd.
―
Kopran Limited
―
Lincoln Pharmaceuticals Ltd
―
Wanbury Limited
―